RT Journal
A1 Kosiborod M, Inzucchi SE, Krumholz HM, Masoudi FA, Goyal A, Spertus JA
T1 IS insulin the preferred compound in lowering glucose levels in patients after a myocardial infarction?—reply
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2009
FD September 28
VO 169
IS 17
SP 1633
OP 1638
DO 10.1001/archinternmed.2009.327
UL http://dx.doi.org/10.1001/archinternmed.2009.327
AB 

			While not the main objective of our study (which was to evaluate whether normalization of glucose levels is associated with better survival), the impact of insulin therapy on patient outcomes in a setting of AMI is an important and controversial issue. While treatment thresholds and therapeutic goals remain subjects of intense debate, professional societies currently endorse glucose control in patients with AMI and significant hyperglycemia (blood glucose level >180 mg/dL [to convert to millimoles per liter, multiply by 0.0555]),2 and insulin remains the only reliable way to effectively lower glucose levels in hospitalized patients.